USPTO serial 79102816
LEADING LIGHT FOR LIFE
Reviewed by CopyMark Law Group
Reg. 4192508Status 404
- Filing date
- Status date
- Registration date
- Aug 21, 2012
- Examiner
- HESIK, APRIL ANNE
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LEADING LIGHT FOR LIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42nd St., 17 Fl.NEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides ] | SECTION 71 - CANCELLED | — |
| 042 | [ Testing, inspection or research of pharmaceuticals; ] providing medical research information in the field of pharmaceuticals | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Astellas Pharma Inc.
- Other trademarks owned by Astellas Pharma Inc.
- Other trademarks owned by Astellas Pharma Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named LEADING LIGHT FOR LIFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 12, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 21, 2021 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Oct 23, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 8, 2020 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Dec 10, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 7, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 7, 2018 | INPC | INVALIDATION PROCESSED | — |
| Jun 5, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 5, 2017 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 5, 2017 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Oct 5, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 5, 2017 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 21, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2013 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 13, 2013 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 31, 2013 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 14, 2012 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 10, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 29, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 29, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 21, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 21, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 5, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 5, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 16, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 16, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 16, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 28, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 24, 2012 | ALIE | ASSIGNED TO LIE | — |
| Apr 5, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 4, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 28, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 27, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 14, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 10, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 7, 2011 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 6, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |